COVID-19 update: 1,634 new cases, 32 more deaths, 699 hospitalizations

  • So far, 8,584,750 people have been fully vaccinated against COVID-19 in Illinois, about 67.7% of the state's 12.7 million residents.

    So far, 8,584,750 people have been fully vaccinated against COVID-19 in Illinois, about 67.7% of the state's 12.7 million residents. Associated Press

 
 
Updated 3/9/2022 5:39 PM

State health authorities reported 1,634 new cases of COVID-19 Wednesday, along with 32 more deaths from the respiratory disease.

Illinois hospitals were treating 699 COVID-19 patients Tuesday night, according to the Illinois Department of Public Health.

 

The state's positivity rate for COVID-19 cases is 1.2%, based on a seven-day average.

Total cases statewide stand at 3,042,495, and 33,010 Illinoisans have died since the pandemic began.

On Tuesday, 9,539 more COVID-19 vaccine shots were administered. The seven-day average is 10,323.

So far, 8,584,750 people -- about 67.7% of Illinois' 12.7 million residents -- have been fully vaccinated, according to the U.S. Centers for Disease Control. The CDC defines fully vaccinated as two doses of the Pfizer or Moderna vaccine, or one dose of Johnson & Johnson's.

Of those who are fully vaccinated, 49.4% have received a booster shot.

The federal government has delivered 23,933,245 doses of vaccine to Illinois since distribution began in mid-December 2020, and 21,198,094 shots have been administered.

Labs processed 82,597 virus tests in the last 24 hours.

0 Comments
                                                                                                                                                                                                                       
 
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.